Company Page

Telos

Established in 2019, Telos emerged with a vision of facilitating legal psychedelic-assisted therapy, initially focusing on the therapeutic use of ketamine. With a core belief that psychedelics, starting with ketamine, should be accessible as transformative therapeutic medicines, Telos enables trained, licensed practitioners to integrate these treatments into their practices. The endeavor is driven by a collaborative and empowering model of psychedelic-assisted therapy aimed at tailoring quality care to individual client needs, ensuring their active participation in the treatment process.

Telos Transformational Therapies is the brainchild of co-founders Dr. Rafael Gonzalez-Vizoso and Scott Ross, MA, representing a shared ambition to meld transformative medicine with compassionate, attuned therapeutic care. In a landscape where the essence of personalized therapeutic care is often overshadowed by manualized therapies, Telos stands as a beacon of personalized care and empowering medicines. Committed to quality, compassionate care without compromise, Telos seeks to offer unique, client-centered therapeutic experiences within a collaborative community of practitioners, emphasizing the ongoing inner work of their providers to fully harness the healing potential of ketamine and, in future, other psychedelic medicines.